We tested the hypothesis that the TM, through the functional interplay between the ECM and integrin receptors, could activate signaling pathways which regulate angiogenesis and tumor progression, hence putatively bypassing VEGF-A inhibition. This evidence concerns the gene VEGFA and neoplasm.